J Liver Cancer.  2018 Sep;18(2):142-145. 10.17998/jlc.18.2.142.

Sorafenib Treatment in Advanced Hepatocellular Carcinoma with Tumor Thrombus Nearly Occupying the Entire Right Atrium

Affiliations
  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea. rshdrryu@hanmail.net
  • 2Department of Family Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.

Abstract

Advanced hepatocellular carcinoma (HCC) with tumor thrombus extending through the hepatic veins, inferior vena cava, and right atrium (RA) is very rare. However, whether active treatments such as radiation, transcatheter arterial chemoembolization, and sorafenib in advanced HCC with RA involvement prolong survival is uncertain. We present a rare case of advanced HCC with tumor thrombus nearly occupying the entire RA that was treated with sorafenib. The patient received 400 mg sorafenib twice daily. However, her liver enzyme levels continued to increase and abdominal computed tomography showed an increase in the tumor size in the liver and RA. In the present case, active treatment with sorafenib was ineffective; thus, palliative care may be more beneficial in advanced HCC with extensive RA involvement.

Keyword

Sorafenib; Thrombosis; Hepatocellular carcinoma; Right atrium

MeSH Terms

Carcinoma, Hepatocellular*
Heart Atria*
Hepatic Veins
Humans
Liver
Palliative Care
Thrombosis*
Vena Cava, Inferior
Full Text Links
  • JLC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error